1. Pharmaceutical Industry Palestine Presented By: Talal Nasereddin Chairman Bitzeit Pharmaceutical Co. Email: ceo@bpc.psceo@bpc.ps www.bpc.ps Presented By: Talal Nasereddin Chairman Bitzeit Pharmaceutical Co. Email: ceo@bpc.psceo@bpc.ps www.bpc.ps

2. Industry Brief Six Companies operate in Palestine since early 1970s Working Capital USD 160 Million Generic Manufacturing Companies Estimated market size is $130 million

3. Export Market 25% of total sales goes to export market(Germany, East Europe, MENA) Investment in Algeria Investment in Malta

4. Market share Israeli Foreign Palestinian

5. Key Competitive factors Modern facilities and equipments Improved Management and Production Processes Continuous industry development through international certification (ISOs and GMP)

6. Industry Potential Growth Indicators

8. Window for Cooperation Diversification of products by introducing new products such as: Oncology, natural products, herbal medicine, food supplements, organ transplantation and specialty products as (Freeze dried products) Packaging Grow investments in Algeria

9. investment environment in Palestine Tax exemptions Free trade agreements with Europe, EFTA, USA, CANADA, Turkey, and the Arab Countries Italian government insurance and Funding